News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Oculus Innovative Sciences, Inc. (OCLS) Partner, Quinnova Pharmaceuticals, Inc., Launches Microcyn(R)-Based Atrapro(TM) Products



2/21/2012 9:42:58 AM

PETALUMA, Calif., Feb. 21, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) partner, Quinnova Pharmaceuticals, today launched the Atrapro™ family of products formulated from the Microcyn® Technology platform. The two products, Atrapro™ Antipruritic Hydrogel, which reduces the itch, pain, and burning of various dermatoses, and Atrapro Dermal Spray with preservatives, for wound care, are both prescription products that are being promoted to the U.S. dermatology market.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES